✦ LIBER ✦

Pemetrexed in first-line treatment of non-small cell lung cancer

✍ Scribed by Emilio Esteban; Marta Casillas; Alejo Cassinello

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN4 COST-EFFECTIVENESS OF PEMETREXED IN

✍ CG Pinto; M Manaças; LS Miguel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

19 A Kent and Medway Cancer Network (KMC

✍ Letsa, I.; Mikropoulos, C.; Burcombe, R.; Visioli, A.; Sevitt, T.; Cominos, M.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Randomized phase II trial of first-line

✍ Ahn, Myung-Ju; Yang, James Chih-Hsin; Liang, Jun; Kang, Jin-Hyoung; Xiu, Qingyu; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 550 KB

PCN114 COST-EFFECTIVENESS ANALYSIS OF PE

✍ L Guidi; S Malik; D Valle; Y Asukai; K Taipale 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

An indirect comparison of bevacizumab pl

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB